OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, January 4th
OTCPicks Publisher Newsletter
OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, January 4th SPPH, CSEY, NUBL, FTAR, GDSM, IDOI, AWYI, AEN Our Stocks to Watch today include Spencer Pharmaceutical Inc. (OTC: SPPH), Casey Container Corp. (OTCBB: CSEY), NuMobile Inc. (OTCBB: NUBL), Footstar Inc. (OTCBB: FTAR), Gold Coast Mining Corp. (OTC: GDSM), IDO Security Inc..
(OTCBB: IDOI), Ariel Way Inc. (OTC: AWYI) and Adeona Pharmaceuticals Inc.
(NYSE Amex: AEN).Visit http://otcpicknews.com/emailmarketer/link.phpM940&N52&L1&F=T to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.SPENCER PHARMACEUTICAL INCORPORATED (OTC: SPPH) “Up 6.67% in morning trading” Detailed Quote:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L33&F=T Company Profile:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L38&F=T Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome. SPPH News:December 23 – Spencer Pharmaceutical Inc. Announces Dr. Michael D.
Buschmann Joins the Scientific Advisory Board as New Science Assessor Spencer Pharmaceutical Inc. (OTC: SPPH ), announced the addition of Dr.
Michael D. Buschmann to the Corporation`s Scientific Advisory Board.Dr. Buschmann has joined its Scientific Advisory Board and will also assess new scientific opportunities for the Company.Dr. Buschmann received a B. Engineering Physics from the University of Saskatchewan in 1984, and a Ph.D. in Medical Engineering and Medical Physics from the Division of Health Sciences and Technology at the Massachusetts Institute of Technology and Harvard University in 1992. His postdoctoral training was then completed at the University of Bern in Switzerland in 1994. Since 1994, he has established a multidisciplinary research program as Professor of Biomedical Engineering and Chemical Engineering at Ecole Polytechnique. The program focuses on the use of biomaterials for tissue repair and the development of polymer-based gene and drug delivery systems for Diabetes, Cancer and Inflammatory diseases.
Dr. Buschmann has published 90 articles, 205 conference proceedings and 13 patented or patent pending inventions.He is currently the Director of the FRSQ Group in Biomedical Science and Technology and has received the Innovator Prize from the Quebec Association for Industrial Research (ADRIQ), the Melville Medal from the American Society of Mechanical Engineers (ASME), and the Award of Merit from the Canadian Arthritis Network of Centers of Excellence.”Dr Buschmann will advise and plan product development strategies and assess additional technologies and research that Spencer is interested in licensing into the company. Discussions will also continue in this sense in the coming weeks,” said Dr Max Arella, CEO of Spencer Pharmaceutical Inc.
In addition “we are confident that the experience, dedication and the vision of Dr Buschmann will bring exciting new opportunities into our company adding tremendous value for our shareholders,” further stated Dr Arella.CASEY CONTAINER CORPORATION (OTCBB: CSEY) Detailed Quote:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L04&F=T Company Profile:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L05&F=T Headquartered in Scottsdale, Arizona, Casey Container is engaged in the design and custom manufacture of biodegradable PET, HDPE and other plastic polymer preforms, bottles and containers for use in the bottled water, beverage and consumer products industries. The Company is committed to developing container products that meet clients` demands while addressing environmental issues concerning proliferation of plastic pollution. The Company offers its biodegradable plastic packaging solutions using the breakthrough science of the EcoPure® additive and technology. CSEY News:December 29 – Casey Container To Focus Entirely on Ramping Up Biodegradable Plastic Preforms and Bottle Manufacturing CapacityCompany to Concentrate Its Resources on Meeting Immediate Industry Demand for Biodegradable Plastic Packaging Solutions Casey Container Corp. (OTCBB: CSEY) announced that senior management is focusing on the manufacturing of its preforms which are used to produce biodegradable plastic bottles and containers. This decision comes as the Company has received purchase orders and numerous inquiries for its biodegradable plastic solution for bottled water and other consumer product containers that use traditional plastic materials.In light of this focus, the Company has terminated acquisition negotiations with Mountain Green of Arizona, LLC and will deploy its resources exclusively to meet immediate and escalating demand for biodegradable preforms and bottling products produced using EcoPure®, a revolutionary second-generation proprietary and organic additive licensed to Casey, which when combined with resin used to produce plastic bottles and containers, renders the plastic biodegradable.Over the past several weeks, Casey Container announced receiving purchase orders for its biodegradable plastic preforms from three bottled water companies. These orders include one international and two domestic companies, providing for weekly delivery of approximately 750,000 biodegradable plastic preforms, or nearly 40 million preforms over the first 12 months once production commences in early 2011.Martin Nason, President and CEO of Casey Container, stated, “Strategically, Casey needs to accelerate and concentrate its efforts and resources on its production launch so we can begin shipping biodegradable plastic preforms to our customers, and pursue the numerous inquiries we`ve received from other bottled water and consumer products companies.” Continuing, Nason noted, “Casey has had meaningful discussions with plastic bottle manufacturers centered on joint supply arrangements. These events have led to an execution strategy which will permit us to optimize our time, effort and resources to establish Casey Container as the preferred source for custom biodegradable preforms and bottling products.”According to the Container Recycling Institute, Americans alone consume more than 90 million single use (liter size or smaller) bottled water each day, of which approximately 70 million end up in landfills and incinerators and are not biodegradable.NUMOBILE INCORPORATED (OTCBB: NUBL) “Up 50.00% in morning trading” Detailed Quote:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L34&F=T NuMobile, Inc. operates as an information technology company primarily in the United States. The company provides a range of services, such as voice over IP, network architecting, network implementation, network support, network monitoring, network management, and software as a service primarily to education sector. It also offers cornerstone security policy manager, device portability, mobile security integration, architect design and review, and security auditing solutions to wireless, telecom, hospitality, gaming, and health markets. NuMobile, Inc. markets its products primarily through its sales force, as well as strategic partnerships with value added resellers and distributors. The company was formerly known as Phoenix Interests, Inc. and changed its name to NuMobile, Inc. in July 2009.
NuMobile, Inc. was founded in 1999 and is based in Louisville, Kentucky. NUBL News:January 4 – China Crescent and NuMobile Announce January $160 Million LOI Review and Update in Shanghai to Assess Latest Progress on $1.6 Million Pilot China Crescent Enterprises, Inc. (OTCBB: CCTR) and NuMobile, Inc. (OTCBB:
NUBL) announced senior management is scheduled to convene later this month in Shanghai, China, to review the latest progress on a $1.6 million pilot project that could lead to a $160 million contract.Last year, China Crescent entered into a formal letter of intent (LOI) agreement with an undisclosed Japanese firm to develop and provide 10,000 custom Wi-Fi devices. In conjunction with the LOI, the Japanese firm placed a $1.6 million purchase order for 100 sets of the device in order to conduct a pilot test. NuMobile was been selected by China Crescent to provide a key proprietary software component for the special purpose Wi-Fi communication device. China Crescent and NuMobile senior management are scheduled to meet in approximately two weeks in Shanghai to review the latest customer feedback on the pilot. Following the pilot review, China Crescent and NuMobile plan to conduct a Webcast presentation to provide a progress report on the pilot and LOI.FOOTSTAR INCORPORATED (OTCBB: FTAR) “Up 62.50% in morning trading” Detailed Quote:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L35&F=T Footstar, Inc. is in the process of liquidation and dissolution pursuant to the plan approved by the company’s Board of Directors on March 5, 2009. Previously, the company, through its subsidiaries, operated as a retailer of family footwear through licensed footwear departments and wholesale arrangements in the United States. The company was founded in 1996 and is headquartered in Mahwah, New Jersey.FTAR News:January 4 – Footstar to Buy CPEX Pharmaceuticals Reuters reports that CPEX Pharmaceuticals Inc. (OTC: CPEX) has “agreed to be acquired by a unit of Delaware-based Footstar Inc. (OTCBB: FTAR) for about $76.6 million in cash.”For more details, visit http://otcpicknews.com/emailmarketer/link.phpM940&N52&L36&F=T.GOLD COAST MINING CORPORATION (OTC: GDSM) “Up 7.14% in morning trading” Detailed Quote:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L8&F=T Gold Coast Mining Corp. is pursuing mining acquisitions and joint ventures. The Company currently has a joint venture with Western Sierra Mining Corp. for its Ore Cache and SunGold Mines located in Arizona. The Company currently has 444,887,086 shares issued and outstanding. GDSM News:November 2 – Gold Coast Mining Announces Corporate UpdateGold Coast Mining Corp. (OTC: GDSM) gave the following corporate update: The Company is pleased to announce that all dividend shares of Max Media Group, Inc. (OTC: MXMI) to shareholders of record on August 31, 2009 have been issued and released by Pacific Stock Transfer Company, MXMI`s transfer agent. The Depository Trust Company is processing the distribution of the shares to shareholders who hold shares in brokerage firms or street name.
The Company is distributing all shares to shareholders who hold shares in certificate form. All shares were issued and carry a Pay Date of September 30, 2009. Jason Cooper, Interim CEO of Gold Coast Mining Corp., stated, “With the dividend in transit to shareholders, we are excited to focus all of our efforts on our joint venture projects, continued shareholder transparency and the goal of rebuilding shareholder value. The Company is in the process of preparing and completing its Quarterly Disclosure for the period ended September 30, 2009. We expect to file the Quarterly with Pink Sheets within the next 7-10 days.” Additionally, the Company is currently awaiting a shareholder loan of $25,000 that will be provided to Western Sierra for additional work on the Sun Gold Mine. Western will use the funds for the manpower, sample collection, crushing, grinding and transportation to Western`s concentration tables in Lake Havasu. There Western has the tables, the water and the power for running the samples and reporting on the collected gold. Initially, Western expects to run two sample programs and send a small portion to an outside lab for evaluation. These will be surface samples of both the older workings and the exposed vein structures. IDO SECURITY INCORPORATED (OTCBB: IDOI) “Up 14.29% in morning trading” Detailed Quote:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L1&F=T Headquartered in New York with a subsidiary in Israel, IDO Security designs, develops and markets the patented, UL-certified MagShoe™ weapons metal detection system. MagShoe™ fills a critical void in today`s metal detectors by extending screening to the lower body and feet. MagShoe`s™ unique “shoes-on” design maximizes security, thoroughness and accuracy while eliminating the need to remove shoes for increased convenience and safety. Ideal for security and loss prevention at virtually any facility, MagShoe™ is currently in use at international airports, cruise lines, government agencies, prisons and more.IDOI News:December 1 – IDO Security Receives Letter of Intent From UK Distributor for First Multi-Site Order for New MagShoe 3G™ SeriesIDO Security, Inc. (OTCBB: IDOI), developer of the innovative MagShoe™ shoe scanning device (SSD), today announced that as a result of a successful field trial the Company has received a Letter of Intent for its first multi-site deployment of the new MagShoe 3G™ Series issued by IDO Security`s local agent, Birmingham, UK-based Scan-X Security Ltd.”We are very pleased with the way things are developing for the new 3G series. Our efforts in Europe during the last few months have proven that the multiple pilots and trial runs are an effective means of demonstrating the MagShoe to potential large clients and ultimately receiving orders,” stated IDO Security`s International Sales & Marketing Manager, Dani Werber.ABOUT SCAN-X SECURITY LTD. Scan-X Security is a global provider of threat detection and screening technologies for prisons, transportation, asset protection and corporate applications. Scan-X takes individual products and integrates them to form complete security solutions, providing advanced, high throughput screening systems for people, baggage and freight.ARIEL WAY INCORPORATED (OTCBB: AWYI) “Up 26.67% in morning trading” Detailed Quote:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L64&F=T Ariel Way, Inc. operates as a technology and services company for global communications, multimedia, and digital signage solutions and technologies.
The company develops and deploys solutions for digital signage and interactive media delivered over a combination of satellite, terrestrial, and wireless local networks. Its digital signage service includes technologies using liquid crystal display television and plasma flat screen displays to promote and advertise products and services. The company was incorporated in 2000 and is headquartered in Washington, District Of Columbia.AWYI News:December 15 – Ariel Way and iiGrowth in Strategic Relationship Ariel Way, Inc. (OTC: AWYI), a technology and services company for highly secure global communications, multimedia including digital signage solutions and associated technologies, today announced that it has developed a strategic relationship with iiGrowth, LLC of Washington, DC, a global strategy and management consultancy.Arne Dunhem, Chairman, President, and CEO of Ariel Way said, “We are pleased to have developed a close strategic relationship with iiGrowth.” Arne Dunhem also said, “Gustav Plato, CEO, and Juris Lazdin, President of Government Services, have extensive experience in high technology and government contracting in the US and abroad. I am particularly excited about the services they provide in markets such as cyber security, sustainable technologies, software as a service (cloud computing), and digital media. Leveraging iiGrowth`s expertise in these service areas will be strategically important to Ariel Way and to our customers as we grow through acquisitions and expand the services we offer.”ABOUT IIGROWTH, LLCiiGrowth, LLC is a global strategy and management consultancy with a simple goal: To assist in unlocking the value of business clients and to make them become great. Our experience has taught us that it is not about being big; it is about being great. Idea generation and creativity, business model innovation and growth, and realizing the power of collaboration are at the core of the path to becoming a great company.
Through great personalization of our services we help the clients apply these concepts to create their own path to greatness.ADEONA PHARMACEUTALS INCORPORATED (AMEX: AEN) “Up 22.96% in morning trading” Detailed Quote:
http://otcpicknews.com/emailmarketer/link.phpM940&N52&L1&F=T Adeona is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases. The Company`s strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Currently, Adeona is developing the following product candidates: a prescription medical food for Alzheimer`s disease, and drugs for multiple sclerosis, fibromyalgia, rheumatoid arthritis and age-related macular degeneration. AEN News:December 16 – Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly * Zinc Therapy Demonstrates 67% Reduction in Incidence of Infections * Zinc Research Pioneer, Ananda S. Prasad, M.D., Ph.D., Joins Adeona Scientific Advisory Board Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it has acquired access to clinical data supporting a zinc-based therapy for the prevention of infections in the elderly. This acquisition expands and enhances Adeona`s zinc-based product candidate portfolio that already includes its proprietary zinc-based tablets for use in the dietary management of mild to moderate Alzheimer`s disease and mild cognitive impairment patients, and age-related macular degeneration. In addition, Adeona also announced the appointment of the zinc research pioneer, Ananda S. Prasad, M.D., Ph.D., to the Company`s Scientific Advisory Board.”I am pleased to join the Scientific Advisory Board of Adeona, a company leading the development of zinc-based therapies addressing diseases in the elderly,” said Ananda S. Prasad, M.D., Ph.D. “I look forward to providing guidance as Adeona moves their promising zinc-based product candidates through development.”Zinc for Prevention of Infection in the ElderlyAdeona has entered into an agreement with Dr. Prasad that provides the Company with access to clinical data from a 50 patient, 12-month, randomized, double-blind, placebo-controlled clinical trial that evaluated the prevention of infection in patients age 55 to 87 who were treated with an oral zinc therapy (45 mg elemental zinc per day away from food) or matching placebo. The clinical trial was conducted by Dr. Prasad and co-investigators. The primary endpoint of the clinical trial was the rate of infections between the placebo and zinc treated groups. The results at 12 months demonstrated a 67% reduction in the incidence of infection between the two groups (88 infections in the placebo group versus 29 infections in the zinc treated group) (p less than 0.001).Adeona`s Portfolio of Zinc-Based Therapies for Diseases in the ElderlyAdeona is developing a portfolio of proprietary oral zinc-based therapies that is expected to offer superior benefits including improved convenience, bioavailability and gastrointestinal tolerability for major diseases of the elderly. The Company considers zinc deficiency of the elderly to be a major public health issue, with zinc deficiency implicated in age-related macular degeneration, Alzheimer`s disease, complications of diabetes mellitus and impaired immune function. Declines in serum zinc levels and impaired zinc absorption in the elderly are well documented in multiple clinical studies.
Adeona is currently conducting a controlled clinical trial to test its proprietary zinc-based therapy for Alzheimer`s disease and mild cognitive impairment. All 60 patients should complete their 6 month treatment by the end of March 2011 and it is anticipated that top-line clinical study results should be available shortly thereafter. Adeona`s product candidate for age-related macular degeneration has been successfully evaluated in an 80 patient, randomized, placebo-controlled clinical trial. This trial demonstrated statistically significant improvements in multiple parameters of retinal function.Adeona believes that the product opportunity announced today represents a natural extension of the Company`s leading position in developing oral zinc-based therapies for major diseases in the elderly. According to the U.S. Centers for Disease Control, infections attributable to influenza and pneumonia represent the 4th leading cause of death of people age 65 and over in the United States. Influenza and pneumonia alone are estimated to claim the lives of 58,000 seniors a year and infections in seniors are also a major burden on the public health care system.”We are excited to add a product candidate for the prevention of infection to our zinc-based portfolio. Utilizing our clinical experience from our Alzheimer`s disease and age-related macular degeneration zinc-based product candidates, we have increased opportunities to address the unmet need of zinc deficiency in the elderly,” stated James S. Kuo, M.D., M.B.A., Adeona`s Chairman and CEO. “We are also very pleased to have Dr. Prasad, an esteemed pioneer of zinc therapy with over 50 years of experience devoted to the field, accept our invitation to join our Scientific Advisory Board, and we look forward to his valuable contributions.”ABOUT ANANDA S. PRASAD, M.D., PH.D.Ananda S. Prasad, M.D., Ph.D., a Distinguished Professor of Internal Medicine at Wayne State University School of Medicine and renowned zinc expert, recently received the 2010 Mahidol Award in the Field of Public Health for his groundbreaking research. Among his many achievements, he is credited for identifying zinc deficiency as the underlying cause of growth retardation and hypogonadism that has afflicted millions of children in the developing world. Dr. Prasad estimates that over 2 billion people worldwide currently suffer from zinc deficiency. For over five decades, he has been a vocal advocate of zinc supplementation for diseases characterized by zinc deficiency. Dr. Prasad is the 2007 recipient of the American College of Physicians Award for Outstanding Work in Science as Related to Medicine and has over 200 peer-reviewed publications.OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it..DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies. The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them. Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing. Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company`s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company`s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company`s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://otcpicknews.com/emailmarketer/link.phpM940&N52&L=7&F=T and FINRA at http://otcpicknews.com/emailmarketer/link.phpM940&N52&L=8&F=T. Disclosure: OTCPicks.com and affiliates have been compensated ten thousand dollars by a third party (IAB Media) for this current SPPH email promotion.
OTCPicks.com and affiliates have been compensated fifteen thousand dollars by a third party for CSEY advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.